stage IV melanoma
Showing 1 - 25 of >10,000
Participation Patterns Among Stage IV Melanoma Patients
Not yet recruiting
- Stage IV Melanoma
-
San Francisco, CaliforniaPower Life Sciences
Oct 16, 2023
Anxiety, Stage IV Melanoma Trial in Miami Beach (psilocybin)
Withdrawn
- Anxiety
- Stage IV Melanoma
-
Miami Beach, FloridaMount Sinai Comprehensive Cancer Center
Jun 13, 2022
Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)
Not yet recruiting
- Melanoma
- ABP 206
- +2 more
- (no location specified)
Jun 8, 2023
Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)
Recruiting
- Melanoma Stage III
- +2 more
- Interleukin-2
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Dec 6, 2022
Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)
Completed
- Melanoma
- Skin Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023
Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)
Not yet recruiting
- Melanoma
- Unresectable Melanoma
- Sarilumab
- +2 more
-
Los Angeles, California
- +3 more
Aug 4, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Stage IV Melanoma, Unresectable Stage III Cutaneous Melanoma Trial in Boston
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +3 more
-
Boston, Massachusetts
- +2 more
Sep 17, 2022
Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)
Not yet recruiting
- Melanoma
- Urothelial Carcinoma
-
Berlin, GermanyLocal Institution - 0001
Aug 9, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Natural Killer Cell Therapy
- Temozolomide
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 28, 2022
Melanoma Trial in Providence (Ipilumumab, Nivolumab)
Active, not recruiting
- Melanoma
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Feb 24, 2022
Metastatic Melanoma Trial in Boston (Tremelimumab, MEDI3617)
Active, not recruiting
- Metastatic Melanoma
-
Boston, Massachusetts
- +1 more
Mar 22, 2022
Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)
Completed
- Male Breast Cancer
- +7 more
- propranolol hydrochloride
- Correlative Studies
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 4, 2022
Stage III Melanoma, Stage IV Melanoma Trial in Los Angeles, Denver (TBX-3400)
Recruiting
- Stage III Melanoma
- Stage IV Melanoma
- TBX-3400
-
Los Angeles, California
- +1 more
May 1, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage IV Cutaneous Melanoma AJCC v8
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 17, 2023
Metastatic Melanoma Trial in Louisville (Ipilimumab, GM-CSF)
Completed
- Metastatic Melanoma
-
Louisville, KentuckyJames Graham Brown Cancer Center
Oct 22, 2021
Advanced Melanoma Trial in Beijing (JS001+Imatinib mesylate)
Recruiting
- Advanced Melanoma
- JS001+Imatinib mesylate
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Mar 2, 2022
Metastatic Melanoma Trial in Louisville (Ipilimumab)
Terminated
- Metastatic Melanoma
-
Louisville, KentuckyJames Graham Brown Cancer Center
Oct 22, 2021
Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab
Recruiting
- Unresectable Melanoma
- +3 more
- Sargramostim (GM-CSF)
- Pembrolizumab (anti-PD-1)
-
Boston, Massachusetts
- +1 more
Jul 6, 2022
Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)
Completed
- Stage III Malignant Melanoma of Skin AJCC V6
- Stage IV Malignant Melanoma of Skin
- TAPCells vaccine
-
Santiago, RM, ChileFaculty of Medicine, University of Chile
Nov 21, 2023
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,
Active, not recruiting
- Metastatic Melanoma
- +6 more
- Ibrutinib
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 13, 2023
Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,
Active, not recruiting
- Metastatic Melanoma
- +3 more
- Imiquimod
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 3, 2023
Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 6, 2022
Melanoma Trial in New York (DS-8273a, Nivolumab)
Completed
- Melanoma
- DS-8273a
- Nivolumab
-
New York, New YorkLaura and Isaac Perlmutter Cancer Center
Oct 8, 2021
Melanoma, Cancer Trial in Cambridge (Encorafenib + Binimetinib, Standard Adjuvant Treatment)
Not yet recruiting
- Melanoma
- Cancer
- Encorafenib + Binimetinib
- Standard Adjuvant Treatment
-
Cambridge, England, United KingdomAddenbrooke's Hospital
Oct 15, 2021